CBIO Shares Outstanding History
Below is a table of the CBIO shares outstanding history going back to 2/13/2017:

Date CBIO Shares Outstanding
2/13/20173.30M
2/28/20173.80M
5/4/201716.20M
7/31/201716.39M
10/31/201716.39M
3/15/201845.23M
4/30/201845.39M
7/31/201845.42M
10/29/201845.42M
3/4/201945.52M
4/30/201945.56M
7/26/201945.70M
8/3/20155.83M
10/25/201945.79M
2/7/202045.93M
5/1/202066.31M
7/30/202083.91M
10/29/202084.04M
2/25/2021119.15M
4/29/2021119.22M
7/30/2021119.28M
11/8/2021119.45M
3/25/2022119.71M
3/31/2022119.71M
4/29/2022119.71M
7/29/2022119.71M

Also see: CBIO Market Cap History
CBIO YTD Return
CBIO Historical Shares Outstanding:
+93.15% CAGR
CBIO Historical Shares Outstanding: +93.15% CAGR

Mouse over chart for data details
2/13/2017 ...7/29/2022
Catalyst Biosciences is a research and clinical development biopharmaceutical company. Co.'s complement portfolio consists of the development candidates CB 4332 and CB 2782-PEG. CB 4332 is a wholly owned, improved albumin-fused Complement Factor I (CFI) molecule intended for prophylactic subcutaneous or intravitreal administration in individuals with an imbalance in complement homeostasis or a CFI deficiency. CB 2782-PEG is a potential component 3 degrader product candidate in preclinical development for the treatment of dry age-related macular degeneration. Co. has several engineered protease programs in discovery or early non-clinical development. We show 26 historical shares outstanding datapoints in our coverage of CBIO's shares outstanding history.

Understanding the changing numbers of CBIO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CBIO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CBIO by allowing them to research CBIO shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree CBIO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Catalyst Biosciences (CBIO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

CBLI Shares Outstanding History
CBM Shares Outstanding History
CBMG Shares Outstanding History
CBPO Shares Outstanding History
CCCC Shares Outstanding History
CCEL Shares Outstanding History
CCRN Shares Outstanding History
CCXI Shares Outstanding History
CDAK Shares Outstanding History
CDMO Shares Outstanding History
More Healthcare companies »

 

CBIO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.